Europe Genetic Disease Diagnostics Market Size & Outlook
Related Markets
Europe genetic disease diagnostics market highlights
- The Europe genetic disease diagnostics market generated a revenue of USD 3,263.9 million in 2024.
- The market is expected to grow at a CAGR of 19.3% from 2025 to 2033.
- In terms of segment, next generation sequencing was the largest revenue generating technology in 2024.
- Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 3,263.9 million |
| Market revenue in 2033 | USD 16,279.6 million |
| Growth rate | 19.3% (CAGR from 2025 to 2033) |
| Largest segment | Next generation sequencing |
| Fastest growing segment | Next Generation Sequencing |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Next Generation Sequencing, Array Technology, PCR - based Testing, FISH |
| Key market players worldwide | Abbott, Celera Motion, ElitechGroup, PerkinElmer, Quest Diagnostics Inc, AutoGenomics, Roche Diagnostics, Biorad Medisys, Transgenomic |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.9% of the global genetic disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,550.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genetic Disease Diagnostics Market Scope
Genetic Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Transgenomic | View profile | 101-250 | Omaha, Nebraska, United States, North America | http://www.transgenomic.com |
| Biorad Medisys | View profile | 501-1000 | Pune, Maharashtra, India, Asia | https://bioradmedisys.com/ |
| AutoGenomics | View profile | 51-100 | Vista, California, United States, North America | http://www.autogenomics.com |
| Roche Diagnostics | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Celera Motion | View profile | 101-250 | Bedford, Massachusetts, United States, North America | https://www.celeramotion.com/ |
| ElitechGroup | View profile | 11-50 | https://www.elitechgroup.co.za/ | |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
Europe genetic disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genetic disease diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 61.04% in 2024. Horizon Databook has segmented the Europe genetic disease diagnostics market based on next generation sequencing, array technology, pcr - based testing, fish covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe genetic disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe genetic disease diagnostics market databook
-
Our clientele includes a mix of genetic disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe genetic disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe genetic disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe genetic disease diagnostics market size, by country, 2021-2033 (US$M)
Europe Genetic Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
